Allogene Therapeutics, Inc.（ALLO）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Allogene Therapeutics, Inc.（ALLO）报告了 19 笔 Form 4 交易（最近一笔 2026-08-25）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-25 | Douglas Earl Martin | SVP, General Counsel | 卖出 | 29,697 | $62,958 |
| 2026-06-23 | Kazam Joshua A | 董事 | 买入 | 47,700 | $0 |
| 2026-04-23 | Yoshiyama Annie | SVP, Finance | 卖出 | 9,586 | $22,144 |
| 2026-04-02 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 卖出 | 2,867 | $7,168 |
| 2026-03-18 | Chang David D | President and CEO | 卖出 | 47,763 | $117,975 |
| 2026-03-18 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 卖出 | 4,835 | $11,942 |
| 2026-03-04 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 卖出 | 7,132 | $18,543 |
| 2026-02-04 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 卖出 | 24,001 | $42,242 |
| 2026-02-04 | Yoshiyama Annie | SVP, Finance | 卖出 | 4,167 | $7,167 |
| 2026-02-04 | Douglas Earl Martin | SVP, General Counsel | 卖出 | 22,900 | $40,304 |
| 2026-02-04 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 卖出 | 7,549 | $13,060 |
| 2026-02-04 | Roberts Zachary | EVP of R&D | 卖出 | 35,700 | $63,189 |
| 2026-02-04 | Chang David D | President and CEO | 卖出 | 95,269 | $171,484 |
| 2026-01-23 | Roberts Zachary | EVP of R&D | 卖出 | 26,269 | $40,980 |
| 2025-12-22 | Kazam Joshua A | 董事 | 买入 | 47,700 | $0 |
| 2025-11-19 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 卖出 | 786 | $959 |
| 2025-10-23 | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 卖出 | 36,744 | $46,297 |
| 2025-06-12 | MESSEMER DEBORAH M. | 董事 | 卖出 | 36,885 | $52,377 |
| 2025-04-23 | Yoshiyama Annie | SVP, Finance | 卖出 | 9,601 | $13,537 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25